SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 57.58 |
| Enterprise Value ($M) | 17.31 |
| Book Value ($M) | 103.18 |
| Book Value / Share | 1.83 |
| Price / Book | 0.56 |
| NCAV ($M) | 64.32 |
| NCAV / Share | 1.14 |
| Price / NCAV | 0.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.06 |
| Return on Assets (ROA) | -0.52 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.18 |
| Current Ratio | 5.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 102.40 |
| Assets | 141.26 |
| Liabilities | 38.08 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 7.00 |
| Operating Income | -139.71 |
| Net Income | -127.17 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -102.89 |
| Cash from Investing | 90.19 |
| Cash from Financing | -0.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vaddi Krishna | 13.80 | 16.55 | |
| 13G/A | Flynn James E | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 19,726 | 118,352 | 16.67 | |
| 15,014 | 73,028 | 20.56 | |
| 32,115 | 145,678 | 22.05 | |
| 25,448 | 198,308 | 12.83 | |
| 15,534 | 94,253 | 16.48 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PLRX – Pliant Therapeutics, Inc. | PMVP – PMV Pharmaceuticals, Inc. |
| PRAX – Praxis Precision Medicines, Inc. | PRTA – Prothena Corporation plc |
| PTCT – PTC Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io